Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Implant or insert
Patent
1990-06-27
1994-04-05
Page, Thurman K.
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Implant or insert
424451, 424456, 424464, 514169, 514172, 514173, 514177, 514178, 514182, 514319, 514428, 514462, 514510, 514573, A61K 920, A61K 948, A61K 3156, A61K 3158
Patent
active
053002946
ABSTRACT:
Invented is a Method of Treating Prostatic Adenocarcinoma by employing a steroid 5-.alpha.-reductase inhibiting compound or a combination of steroid 5-.alpha.-reductase inhibiting compounds.
REFERENCES:
patent: 4882319 (1989-11-01), Holt et al.
patent: 4910226 (1990-03-01), Holt et al.
patent: 4937237 (1990-06-01), Holt et al.
patent: 4946834 (1990-08-01), Holt et al.
patent: 4970205 (1990-11-01), Holt et al.
patent: 5017568 (1991-05-01), Holt et al.
patent: 5032586 (1991-07-01), Metcalf et al.
patent: 5041433 (1991-08-01), Holt et al.
patent: 5137882 (1992-08-01), Holt et al.
"Retardation of Prostate Tumor Progression in the Noble Rat by 4-Methyl-4-Aza-Steroidal Inhibitors of 5 Alpha-Reductase", Kadohama et al; J. Natl. Cancer Inst; 74(2):475-86 1985 ISSN 0027-8874.
Gormley, The Urologic Clinics of North America vol. 18; No. 1, pp. 93-98 (1991).
Sandberg, et al. Progress in Cancer Research Therapy vol. 31; No. 2, pp. 477-489 (1984).
Holt et al, J. Med. Chem. vol. 33; No. 3, pp. 937-942 (1990), pp. 943-950.
Holt et al, Med. Chem. vol. 33; No. 3, pp. 943-950 (1990).
Levy et al., J. Steroid Biochem. vol. 34; Nos. 1-6, pp. 571-575 (1989).
The Prostate 18:215-227, (1991); Brooks, et al.
J. Steroid Biochem (24), 1986, 887-86; Cooke, et al.
Bio Chemistry (28), 1989, Brandt, et al.
Liang et al., Endocrinology, 117 No. 2, 571-579 (1985).
Petrow et al., Novel Approaches to Cancer Chemotherapy, pub: Academic Press, Inc., CH.8.V 269-304 (1984).
Azpuru C.
Dustman Wayne J.
Lentz Edward T.
Page Thurman K.
SmithKline Beecham Corporation
LandOfFree
Method of treating prostatic adenocarcinoma does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating prostatic adenocarcinoma, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating prostatic adenocarcinoma will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-509445